Author(s): Thiboutot MM, Kannan S, Kawalekar OU, Shedlock DJ, Khan AS, , Thiboutot MM, Kannan S, Kawalekar OU, Shedlock DJ, Khan AS,
Abstract Share this page
Abstract Chikungunya virus is a mosquito-borne emerging pathogen that has a major health impact in humans and causes fever disease, headache, rash, nausea, vomiting, myalgia, and arthralgia. Indigenous to tropical Africa, recent large outbreaks have been reported in parts of South East Asia and several of its neighboring islands in 2005-07 and in Europe in 2007. Furthermore, positive cases have been confirmed in the United States in travelers returning from known outbreak areas. Currently, there is no vaccine or antiviral treatment. With the threat of an emerging global pandemic, the peculiar problems associated with the more immediate and seasonal epidemics warrant the development of an effective vaccine. In this review, we summarize the evidence supporting these concepts.
This article was published in PLoS Negl Trop Dis
and referenced in Medical Safety & Global Health